Aprea Therapeutics, Inc. (APRE)
NASDAQ·Healthcare·Biotechnology
$0.85
-1.87%
Mkt Cap $5.40M
Next Earnings
In 14 daysTue, May 12, 2026
EPS Estimate
-$1.09
2 analysts
Revenue Estimate
$150.00K
Last quarter: beat by +15.79% on EPS, +0.00% on revenue.
EPS — Estimate vs Actual
Mkt Cap
$5.40M
P/E
—
Fwd P/E
—
P/S
18.89
Rev TTM
—
EPS TTM
-$1.98